Related Experiment Video
Updated: May 28, 2026
09:15
In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Initiation and reinitiation of anticoagulation therapy
1Kaiser Permanente Colorado, Aurora, CO 80011, USA. dan.m.witt@kp.org
Seminars in Hematology
|October 18, 2011
Summary
Initiating anticoagulant therapy requires understanding drug properties and patient factors. Careful selection and dosing are crucial for efficacy and safety, especially in patients with renal dysfunction or obesity.
Area of Science:
- Pharmacology
- Pharmacokinetics
- Pharmacodynamics
Background:
- Optimal anticoagulation therapy ensures patient safety and therapeutic outcomes.
- Initiating anticoagulation therapy presents challenges, particularly regarding resumption after invasive procedures.
Purpose of the Study:
- To review challenges in initiating anticoagulation therapy.
- To provide guidance on anticoagulant selection and dosing in specific patient populations.
Main Methods:
- Review of current evidence on anticoagulant initiation.
- Analysis of factors influencing anticoagulant choice and dosage.
Main Results:
- Initiating unfractionated heparin (UFH), low-molecular-weight heparin (LMWH), or fondaparinux is complex in renal dysfunction and obesity.
- UFH is preferred for severe renal dysfunction; LMWH doses should be based on actual body weight in obese patients.
- No definitive evidence supports one initial warfarin dose over another.
Conclusions:
- Anticoagulant initiation requires careful patient selection due to bleeding risks.
- Understanding drug pharmacology, pharmacokinetics, and pharmacodynamics is essential for safe and effective anticoagulation.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.